Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

3 years ago 350

Moderna shares plunged 12.3% successful premarket trading connected Thursday aft income of the company’s Covid-19 vaccine fell abbreviated of Wall Street analysts’ estimates by much than a cardinal dollars.

The institution reported full gross of $5 cardinal for the 3rd 4th of the year, 20% abbreviated of the FactSet expert statement estimation of $6.2 billion. Spikevax, Moderna‘s (ticker: MRNA) Covid-19 vaccine, is the company’s lone product.

The...

Read Entire Article

Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

Related

How To Improve Websites SEO Performance with Guest Posts

Stock market news live updates: Stock futures rise after Nas...

Good News for Retirees: RMD Formula Changing for First Time ...

Ford books $8.2 billion fourth-quarter profit on Rivian inve...

Trending

Popular

Canadian legislator calls for investigation into video of a ...

Derek Chauvin Gets 22.5 Years As Calls Grow For Congress To ...

Police identify 5 people killed in a hot-air balloon crash i...

7-yo girl drowns in river

Potato Chips, Fatty Lunches Raise Heart Risks